Latest News
-
A Physician Travels to South Asia Seeking Enduring Lessons From the Eradication of Smallpox
-
Your Doctor or Your Insurer? Little-Known Rules May Ease the Choice in Medicare Advantage
-
KFF Health News' 'What the Health?': The Supreme Court and the Abortion Pill
-
California Is Expanding Insurance Access for Teenagers Seeking Therapy on Their Own
-
Virtual Event – Primary Care Shortage
On Wednesday, April 3 at Noon ET, watch and engage with a panel of primary-care experts on the extent of the shortage, how it varies geographically and for different populations, the impact on people’s health, and what can be done to address it.
-
Medicare Spending on Ozempic and Other GLP-1s Is Skyrocketing
This post analyzes the latest data on Medicare Part D spending on GLP-1 drugs, initially approved to treat diabetes but in high demand as treatments for obesity, and shows how spending on these drugs has increased substantially in recent years.
-
What to Know About PEPFAR
As the President’s Emergency Plan for AIDS Relief receives a one-year extension after almost 6 months of reauthorization discussions, learn more about the history, funding, and future outlook of the initiative.
-
Beyond the Data by Drew Altman
In his regular Beyond the Data columns, CEO Drew Altman discusses what the data, polls, and journalism produced by KFF mean for policy and for people.